Updated:
Scintilla Pharmaceuticals
Scintilla Pharmaceuticals is a San Diego-based single-family office investing in healthcare and life sciences. Sector-focused mandate with undisclosed AUM.
Scintilla Pharmaceuticals
Scintilla Pharmaceuticals is structured as a single-family office located in San Diego, California. The firm's name and headquarters location suggest its wealth was generated through the pharmaceutical sector, with a mandate to invest in healthcare-related opportunities. No founding year or named principals are publicly available. The firm's investment strategy centers on the biotechnology and life sciences verticals, consistent with its pharmaceutical heritage. It likely engages in direct investments and co-investments in therapeutic companies, including those at clinical-stage or early-commercialization phases. Public records do not disclose specific portfolio companies or co-investors. Team size and additional offices are not publicly documented. The firm may maintain philanthropic structures or operate through a broader family office vehicle, though no such entities are named in public sources. Recent activity data is unavailable, as the firm does not appear in mainstream media or regulatory filings. The structural differentiator for Scintilla is its singular focus on the pharmaceutical and life sciences sector, unusual among family offices that typically diversify across multiple asset classes. This sector-concentrated mandate implies deep domain expertise and a long-term investment horizon, likely informed by the founding family's own industry experience.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
San Diego
Corporate office
San Diego, CA, United States
Sector focus
Frequently asked questions
What is the investment focus of Scintilla Pharmaceuticals?
Scintilla Pharmaceuticals focuses on the healthcare and life sciences sectors, particularly biotechnology and therapeutics. The firm is likely to invest in companies developing novel drugs or medical technologies, given its pharmaceutical roots. Public sources do not specify preferred investment stages or deal structures.
Does Scintilla Pharmaceuticals act as a direct investor or fund-of-funds?
No explicit public information is available about Scintilla's investment vehicle preferences. Given its sector focus, it likely pursues direct investments in private companies, possibly alongside co-investors. The firm may also participate in venture capital funds focused on life sciences.
Where does the wealth for Scintilla Pharmaceuticals originate?
The firm's name suggests its wealth was generated through the pharmaceutical industry, likely from the founding family's involvement in drug development or commercialization. No specific individual or company has been publicly linked to the entity.
Is Scintilla Pharmaceuticals a single-family office or multi-family office?
Public records and the firm's naming convention indicate it is structured as a single-family office. The concentration on a single sector supports this, as multi-family offices typically diversify across industries to serve multiple families. However, no official confirmation is available.
Who leads investment decisions at Scintilla Pharmaceuticals?
No named principals or investment professionals are publicly associated with Scintilla Pharmaceuticals. The absence of publicly filed reports or media coverage means its leadership team is unknown outside the organization.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: